0000059478-24-000139.txt : 20240603
0000059478-24-000139.hdr.sgml : 20240603
20240603161423
ACCESSION NUMBER: 0000059478-24-000139
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240603
FILED AS OF DATE: 20240603
DATE AS OF CHANGE: 20240603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Norton Johna
CENTRAL INDEX KEY: 0001702471
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06351
FILM NUMBER: 241013753
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ELI LILLY & Co
CENTRAL INDEX KEY: 0000059478
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 350470950
STATE OF INCORPORATION: IN
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: LILLY CORPORATE CTR
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
BUSINESS PHONE: 3172762000
MAIL ADDRESS:
STREET 1: LILLY CORPORATE CENTER
STREET 2: DROP CODE 1094
CITY: INDIANAPOLIS
STATE: IN
ZIP: 46285
FORMER COMPANY:
FORMER CONFORMED NAME: LILLY ELI & CO
DATE OF NAME CHANGE: 19941024
4
1
wk-form4_1717445655.xml
FORM 4
X0508
4
2024-06-03
0
0000059478
ELI LILLY & Co
LLY
0001702471
Norton Johna
LILLY CORPORATE CENTER
INDIANAPOLIS
IN
46285
0
1
0
0
EVP, Global Quality
1
Common Stock
2024-06-03
4
S
0
7056
819.38
D
25428
D
Common Stock
402
I
401(k)
Common Stock
1770
I
401(k) - by partner
Common Stock
128
I
by partner
The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The reporting person disclaims beneficial ownership of the reported securities except to the extent of her pecuniary interest therein.
/s/ Jonathan Groff for Johna Norton, pursuant to authorization on file
2024-06-03